Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.60 -0.04 (-5.91%)
At close: Aug 20, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Asset Utilization Ratio (2025 - 2026)

Citius Pharmaceuticals' (CTXR) quarterly Asset Utilization Ratio came in at 0.04 in Q1 2026, up 41.44% on a QoQ basis from 0.03 in Q4 2025.

Citius Pharmaceuticals (CTXR) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Citius Pharmaceuticals (CTXR) has 2 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.38
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.20
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.90
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.54
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.13
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.13
10 Citius Pharmaceuticals 15.60 Mn 15.60 Mn 1.00 Mn 0.05

Historic Data

Download Data
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 0.03